Jen-chung Ko
Hsin Chu Branch
Hsinchu, TNQ, Taiwan
Hsinchu, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
BMP4-driven morphogenetic reprogramming sustains EGFR-TKI resistance via SOX2 suppression and EMT activation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 23, 2025
Safety of peripheral intravenous administration of hypertonic saline: a systematic review and meta-analysis.
Journal: Frontiers in medicine
Published: September 13, 2025
Downregulation of Rad51 Expression and Activity Potentiates the Cytotoxic Effect of Osimertinib in Human Non-Small Cell Lung Cancer Cells.
Journal: Chemotherapy
Published: April 18, 2024
Optimizing immunofluorescence with high-dynamic-range imaging to enhance PD-L1 expression evaluation for 3D pathology assessment from NSCLC tumor tissue.
Journal: Scientific reports
Published: March 29, 2024
T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study).
Journal: American journal of cancer research
Published: May 09, 2023
Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.
Journal: Cancer medicine
Published: February 15, 2023
Cone-Beam Computed-Tomography-Derived Augmented Fluoroscopy-Guided Biopsy for Peripheral Pulmonary Nodules in a Hybrid Operating Room: A Case Series.
Journal: Diagnostics (Basel, Switzerland)
Published: December 28, 2022
Incidence of and Risk Factors for Acute Kidney Injury During Antituberculosis Treatment: A Prospective Cohort Study and Literature Review.
Journal: Infectious diseases and therapy
Published: December 01, 2022
A deep learning model using chest X-ray for identifying TB and NTM-LD patients: a cross-sectional study.
Journal: Insights into imaging
Published: November 27, 2022
Heat shock protein 90 inhibitor 17-AAG down-regulates thymidine phosphorylase expression and potentiates the cytotoxic effect of tamoxifen and erlotinib in human lung squamous carcinoma cells.
Journal: Biochemical pharmacology
Published: June 04, 2022
Nitroglycerin-induced downregulation of AKT- and ERK1/2-mediated radiation-sensitive 52 expression to enhance pemetrexed-induced cytotoxicity in human lung cancer cells.
Journal: Toxicology research
Published: November 22, 2021
Downregulation of p38 MAPK Activation and Radiation-Sensitive 52 Expression Enhances 5-Fluorouracil and Erlotinib-Induced Cytotoxicity in Human Lung Squamous Cells.
Journal: Pharmacology
Published: April 07, 2021
Last Updated: 09/26/2026